IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern

Por um escritor misterioso

Descrição

IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Pharmaceutics, Free Full-Text
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Vr 3326 Hk (ATCC), Bioz
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Peptide–Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Structural basis of spike RBM-specific human antibodies counteracting broad SARS-CoV-2 variants
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Multivalent antibodies show high potency against SARS-CoV-2 in new study
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
PDF) IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity: Cell
IgG-like bispecific antibodies with potent and synergistic neutralization  against circulating SARS-CoV-2 variants of concern
Viruses, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)